High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced ... - 0 views
-
IV vitamin C shown to augment cancer killer effect of chemotherapy. This study looked at ovarian cancer in animal models and in humans. The effect--a synergistic effect was found that promoted tumor destruction. The great thing about IV vitamin C is the benefit but also the very low side effect profile.
Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis - 1 views
-
Padayatty and colleagues showed that high-level ascorbic acid plasma concentrations could only be achieved by intravenous administration
-
No patient in the low or high dose ascorbic acid treatment arms of this study suffered any identifiable adverse event
-
a pharmacologic ascorbic acid treatment strategy in critically ill patients with severe sepsis appears to be safe
- ...7 more annotations...
-
Study finds IV vitamin C in patients with sepsis is very safe and blunts the effects (endothelial damage, end organ damage...) of sepsis. Of note, the IV vitamin C group reached serum levels of ascorbic acid of 1,592 to 5,722 micromol/L. The IV groups maintained elevated serum C levels for up to 96 hours post infusion.
Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of a... - 0 views
-
Very nice mouse study. They reduced hypoxia signialing, HIF-1alpha, via daily vitamin C administration. Also a very interesting point, that the vitamin C had a much longer half life within the tumor than normal tissue-up to 48 hours compared to 30 minutes in normal. So, that begs the question, what does higher dose do? In this study they also saw a reduction in angiogenesis and tumor growth.
Effect of high-dose intravenous vitamin C on inflammation in cancer patients - 0 views
Urinary glucose and vitamin C. [Am J Clin Pathol. 1977] - PubMed result - 0 views
-
vitamin C added, false-positive tests for glucose were found
« First
‹ Previous
61 - 80 of 168
Next ›
Last »
Showing 20▼ items per page